Gene · 837
Papers3,388
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,388
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Pyroptosis-Related Gene Prognostic Index Associated with Tumor Immune Infiltration for Pancreatic Cancer. | Int J Mol Sci | 2022 | 35682857 | PubTator, text mining | PubMed |
| Salmonella enterica Serovar Typhimurium Induces NAIP/NLRC4- and NLRP3/ASC-Independent, Caspase-4-Dependent Inflammasome Activation in Human Intestinal Epithelial Cells. | Infect Immun | 2022 | 35678562 | PubTator, text mining | PubMed |
| Development of a Prognostic Model Based on Pyroptosis-Related Genes in Pancreatic Adenocarcinoma. | Dis Markers | 2022 | 35677632 | PubTator, text mining | PubMed |
| Role of Pyroptosis in Inflammatory Bowel Disease (IBD): From Gasdermins to DAMPs. | Front Pharmacol | 2022 | 35677444 | PubTator, text mining | PubMed |
| Role of Licochalcone A in Potential Pharmacological Therapy: A Review. | Front Pharmacol | 2022 | 35677438 | PubTator, text mining | PubMed |
| GATA1 regulates the microRNA‑328‑3p/PIM1 axis via circular RNA ITGB1 to promote renal ischemia/reperfusion injury in HK‑2 cells. | Int J Mol Med | 2022 | 35674159 | PubTator, text mining | PubMed |
| Multiomics Data Analysis and Identification of Immune-Related Prognostic Signatures With Potential Implications in Prognosis and Immune Checkpoint Blockade Therapy of Glioblastoma. | Front Neurol | 2022 | 35669882 | PubTator, text mining | PubMed |
| Pyroptosis-related prognosis model, immunocyte infiltration characterization, and competing endogenous RNA network of glioblastoma. | BMC Cancer | 2022 | 35658846 | PubTator, text mining | PubMed |
| Prognostic and Immune Implications of a Novel Pyroptosis-Related Five-Gene Signature in Breast Cancer. | Front Surg | 2022 | 35656090 | PubTator, text mining | PubMed |
| Pyroptosis: Role and Mechanisms in Cardiovascular Disease. | Front Cardiovasc Med | 2022 | 35647057 | PubTator, text mining | PubMed |
| Identification of a Pyroptosis-Related Gene Signature for Predicting the Immune Status and Prognosis in Lung Adenocarcinoma. | Front Bioeng Biotechnol | 2022 | 35646872 | PubTator, text mining | PubMed |
| Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis. | Acta Pharm Sin B | 2022 | 35646543 | PubTator, text mining | PubMed |
| Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases. | Acta Pharm Sin B | 2022 | 35646540 | PubTator, text mining | PubMed |
| Characterization of caspase-2 inhibitors based on specific sites of caspase-2-mediated proteolysis. | Arch Pharm (Weinheim) | 2022 | 35642311 | PubTator, text mining | PubMed |
| Expression of human caspase-4 in the gingival epithelium affected with periodontitis: Its involvement in Porphyromonas gingivalis-challenged gingival epithelial cells. | Arch Oral Biol | 2022 | 35640321 | PubTator, text mining | PubMed |
| Pyroptosis-related genes regulate proliferation and invasion of pancreatic cancer and serve as the prognostic signature for modeling patient survival. | Discov Oncol | 2022 | 35633405 | PubTator, text mining | PubMed |
| Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects. | Pharmaceuticals (Basel) | 2022 | 35631448 | PubTator, text mining | PubMed |
| Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells. | Nutrients | 2022 | 35631261 | PubTator, text mining | PubMed |
| Activation and Function of NLRP3 Inflammasome in Bone and Joint-Related Diseases. | Int J Mol Sci | 2022 | 35628185 | PubTator, text mining | PubMed |
| Pyroptosis and Its Role in SARS-CoV-2 Infection. | Cells | 2022 | 35626754 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/837/papers?page=44